Fresenius Medical Care AG & Co. KGaA (ETR:FME) PT Set at €82.00 by Nord/LB

Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €82.00 ($95.35) target price from analysts at Nord/LB in a research report issued to clients and investors on Thursday, Borsen Zeitung reports. The firm currently has a “buy” rating on the stock. Nord/LB’s target price points to a potential upside of 16.28% from the company’s current price.

A number of other equities research analysts have also weighed in on FME. JPMorgan Chase & Co. set a €90.80 ($105.58) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday. Goldman Sachs Group set a €80.00 ($93.02) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, February 20th. Credit Suisse Group set a €81.00 ($94.19) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Thursday, February 20th. Berenberg Bank set a €89.95 ($104.59) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, February 20th. Finally, UBS Group set a €95.00 ($110.47) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the company. Fresenius Medical Care AG & Co. KGaA presently has an average rating of “Buy” and a consensus price target of €81.89 ($95.22).

FME traded down €1.90 ($2.21) during mid-day trading on Thursday, reaching €70.52 ($82.00). 1,023,345 shares of the company traded hands, compared to its average volume of 704,197. The stock has a market capitalization of $20.97 billion and a P/E ratio of 17.81. The company has a quick ratio of 0.73, a current ratio of 1.02 and a debt-to-equity ratio of 104.49. The company’s fifty day moving average price is €71.05 and its 200-day moving average price is €65.10. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €57.24 ($66.56) and a 52-week high of €81.10 ($94.30).

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More: What are no-load funds?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.